Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.47 -0.03 (-6.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Share-based Compensation (2021 - 2026)

Updated

Reviva Pharmaceuticals Holdings (RVPH) posted Share-based Compensation of $214,565 for Q2 2026, down 45.7% from $395,277 a year earlier and down 63.3% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Share-based Compensation (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Reviva Pharmaceuticals Holdings was $1.71 million, down 22.7% year-over-year; for FY2025, it came in at $2.23 million, up 36.6% from FY2024.

  • Annual Share-based Compensation shows a three-year compound annual growth rate of 132.7% (FY2022 to FY2025).
  • In prior years, Reviva Pharmaceuticals Holdings' Share-based Compensation was $1.63 million in FY2024 (-52.2%), $3.41 million in FY2023 and $176,735 in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Share-based Compensation since Q1 2023.
  • On a year-over-year basis, Share-based Compensation has declined in each of the last three quarters, with growth averaging 16.5% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2023, with growth of 763.4%; the weakest was Q2 2024, with a decline of 86.3%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $584,439 (Q1 2026), $455,084 (Q4 2025) and $458,379 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Reviva Pharmaceuticals Holdings 6.16 Mn 6.16 Mn - 214,565.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 214,565.00
Mar 31, 2026 584,439.00
Dec 31, 2025 455,084.00
Sep 30, 2025 458,379.00
Jun 30, 2025 395,277.00
Mar 31, 2025 919,119.00
Dec 31, 2024 554,216.00
Sep 30, 2024 348,057.00
Jun 30, 2024 358,993.00
Mar 31, 2024 369,075.00
Dec 31, 2023 390,598.00
Sep 30, 2023 350,410.00
Jun 30, 2023 2.62 Mn
Mar 31, 2023 51,527.00
Dec 31, 2022 56,586.00
Sep 30, 2022 40,587.00
Jun 30, 2022 39,876.00
Mar 31, 2022 39,686.00
Dec 31, 2021 62,034.00
Sep 30, 2021 27,590.00
API Access

Reviva Pharmaceuticals Holdings Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RVPH&period=max&api_key=YOUR_API_KEY